Citation: | Peng PENG, Yang XIANG. Reflecting the Achievements of Practice and Leading the Future Direction: Interpretation on Cervical Cancer Staging of the International Federation of Obstetrics and Gynecology in 2018[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 12-15. DOI: 10.3969/j.issn.1674-9081.20190164 |
[1] |
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynaecol Obstet, 2009, 105:103-104. DOI: 10.1016/j.ijgo.2009.02.012
|
[2] |
Bhatla N, Denny L.FIGO Cancer Report 2018[J]. Int J Gynaecol Obstet, 2018, 143:2-3. https://www.ncbi.nlm.nih.gov/pubmed/30306587
|
[3] |
Matsuo K, Machida H, Mandelbaum RS, et al. Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm:trends and characteristics in the United States[J]. J Gynecol Oncol, 2018, 29:e85.
|
[4] |
Machida H, Mandelbaum RS, Mikami M, et al. Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer:trachelectomy vs hysterectomy[J]. Am J Obstet Gynecol, 2018, 219:461.e1-461.e18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648708/
|
[5] |
Li J, Wu X, Li X, et al. Abdominal radical trachelectomy:Is it safe for IB1 cervical cancer with tumors >/=2 cm?[J]. Gynecol Oncol, 2013.131:87-92. DOI: 10.1016/j.ygyno.2013.07.079
|
[6] |
Plante M.Evolution in fertility-preserving options for early-stage cervical cancer:radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy[J]. Int J Gynecol Cancer, 2013, 23:982-989. DOI: 10.1097/IGC.0b013e318295906b
|
[7] |
Marchiole P, Benchaib M, Buenerd A, et al. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation):a comparative study with laparoscopic-assisted vaginal radical hysterectomy(LARVH)[J]. Gynecol Oncol, 2007, 106:132-141. DOI: 10.1016/j.ygyno.2007.03.009
|
[8] |
Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?[J]. Gynecol Oncol, 2004, 92:525-529. DOI: 10.1016/j.ygyno.2003.11.020
|
[9] |
Selman TJ, Mann C, Zamora J, et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer:a systematic review and meta-analysis[J]. CMAJ, 2008, 178:855-862. DOI: 10.1503/cmaj.071124
|
[10] |
Singh N, Arif S.Histopathologic parameters of prognosis in cervical cancer-a review[J]. Int J Gynecol Cancer, 2004, 14:741-750.
|
[11] |
Ramirez PT, Jhingran A, Macapinlac HA, et al.Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer:a prospective correlation of surgical findings with positron emission tomography/computed tomography findings[J]. Cancer, 2011, 117:1928-1934. DOI: 10.1002/cncr.25739
|
[12] |
Pol FJ, Zusterzeel PL, van Ham MA, et al.Satellite lymphovascular space invasion:An independent risk factor in early stage cervical cancer[J]. Gynecol Oncol, 2015, 138:579-584. DOI: 10.1016/j.ygyno.2015.06.035
|
[13] |
Hutchcraft ML, Smith B, McLaughlin EM, et al.Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer[J]. Gynecol Oncol, 2019, 153:255-258. DOI: 10.1016/j.ygyno.2019.01.026
|
[14] |
Sedlis A, Bundy BN, Rotman MZ, et al.A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy:A Gynecologic Oncology Group Study[J]. Gynecol Oncol, 1999, 73:177-183. DOI: 10.1006/gyno.1999.5387
|
[15] |
Matsuo K, Machida H, Mandelbaum RS, et al. Validation of the 2018 FIGO cervical cancer staging system[J]. Gynecol Oncol, 2019, 152:87-93. DOI: 10.1016/j.ygyno.2018.10.026
|
[16] |
Wright JD, Matsuo K, Huang Y, et al.Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines[J]. Obstet Gynecol, 2019, 134:49-57. DOI: 10.1097/AOG.0000000000003311
|
[17] |
Ayhan A, Aslan K, Oz M, et al. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer[J]. Arch Gynecol Obstet, 2019, 300:675-682. DOI: 10.1007/s00404-019-05232-7
|